IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11352329 B1

PDFFull Text
Date of Patent:
Jun. 07, 2022

Filed:

Jul. 09, 2020

Hiv protease inhibitors

Applicant:

Gilead Sciences, Inc., Foster City, CA (US);

Inventors:

Zhenhong R. Cai, Palo Alto, CA (US);

Aesop Cho, Mountain View, CA (US);

Ana Zurisadai Gonzalez Buenrostro, San Mateo, CA (US);

Xiaochun Han, San Jose, CA (US);

Salman Y. Jabri, San Francisco, CA (US);

Ryan McFadden, Foster City, CA (US);

Yingmei Qi, Foster City, CA (US);

Johannes Voigt, Cambridge, MA (US);

Jie Xu, Foster City, CA (US);

Lianhong Xu, Palo Alto, CA (US);

Hong Yang, Fremont, CA (US);

Assignee:

Gilead Sciences, Inc., Foster City, CA (US);

Attorney:
Primary Examiner:

Samantha L Shterengarts

Int. Cl.
CPC ...
C07D 247/00 (2006.01); A61P 31/18 (2006.01); C07D 401/10 (2006.01); C07D 403/14 (2006.01); C07D 233/88 (2006.01); C07D 487/04 (2006.01); C07D 417/10 (2006.01); C07D 471/04 (2006.01); C07D 417/14 (2006.01); C07D 491/107 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 413/14 (2006.01); C07D 403/10 (2006.01); C07D 413/10 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 247/00 (2013.01); A61P 31/18 (2018.01); C07D 233/88 (2013.01); C07D 401/10 (2013.01); C07D 401/14 (2013.01); C07D 403/10 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 413/10 (2013.01); C07D 413/14 (2013.01); C07D 417/10 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 491/107 (2013.01); A61K 45/06 (2013.01);
Abstract

The invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of Formula I, processes for preparing compounds of Formula I, therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS symptoms in a mammal using compounds of Formula I.

Find Patent Forward Citations

Loading…